CGEM Dividend History & Analysis | N/A Yield

CGEM has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of February 2026, Cullinan Oncology (CGEM) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
ABBV 387,093 M 3.34% 7.54%
AMGN 198,244 M 3.21% 5.93%
GILD 176,133 M 2.79% 5.63%
HLN 46,623 M 1.76% 2.46%
BIM 13,627 M 0.74% 0.75%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
BTX 1,425 M 134% 95.6%
HLN 46,623 M 30.1% 100%
AMGN 198,244 M 7.84% 100%
BIM 13,627 M 9.76% 96.0%
ABBV 387,093 M 5.98% 100%

Quality Dividend Peers in Biotechnology

AMGN
Amgen
 3.21% Yield
GILD
Gilead Sciences
 2.79% Yield

CGEM Dividend History: as of February 2026

No dividends paid yet.

CGEM Dividend FAQ

Cullinan Therapeutics (NASDAQ: CGEM) is a clinical-stage biotech focused on small-molecule and biologic therapies for oncology and autoimmune disorders. Its lead assets include zipalertinib, a bioavailable inhibitor now in a Phase 3 trial for non-small cell lung cancer (NSCLC), and CLN-978, a T-cell engager targeting systemic lupus erythematosus and rheumatoid arthritis. Additional early-stage programs comprise CLN-619 (monoclonal antibody for solid tumors and multiple myeloma), CLN-049 (bispecific antibody for AML/MDS and MRD-positive AML), and CLN-617 (fusion protein for solid tumors). The company collaborates with Adimab on antibody discovery and with Taiho Pharmaceutical on zipalertinib co-development; it rebranded from Cullinan Oncology to Cullinan Therapeutics in April 2024.

What is the Dividend Yield of CGEM?

As of February 2026, CGEM`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 12.23.

Does CGEM pay a dividend?

As of February 2026 CGEM does not pay a dividend.

How often does CGEM pay dividends?

Over the last 12 months, CGEM has issued dividend payments.

CGEM dividend forecast

Based on historical data, the forecasted dividends per share for CGEM for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).
This suggests the dividend will remain relatively stable.

Will CGEM pay dividends in 2026?

The next Ex-Dividend date for Cullinan Oncology (CGEM) is currently unknown.

What is the next Ex-Dividend Date for CGEM?

The next Ex-Dividend date for Cullinan Oncology (CGEM) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of CGEM?

CGEM's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of CGEM?

CGEM's 5-Year Yield on Cost is -%. If you bought CGEM's shares at 36.22 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of CGEM?

CGEM Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does CGEM have a good Dividend Yield?

CGEM`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of CGEM?

The Dividend Payout Ratio of CGEM is unknown.

What is the Dividend Rating of CGEM?

CGEM`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

CGEM Outstanding Shares Analysis

What is the Trend in CGEM's Outstanding Shares?

Cullinan Oncology's outstanding shares have increased by approximately 17.43% annually over the past 3 years (Trend Reliability: 100.0%).

Significant dilution: Heavy share issuance is diluting existing shareholders. Even if total dividends paid increase, your dividend per share may stagnate or decline.

Has CGEM ever had a Stock Split?

Yes, the last stock split was on Aug 31, 2009 with a ratio of 2:1.

This was a forward split: Each share became 2 shares, lowering the price proportionally. The dividend per share was also adjusted downward by the same ratio, so total dividend income remained unchanged.

Year Number of Shares Annual Growth Rate
2019 1,071,000
2020 41,977,000 +3819.42%
2021 43,643,000 +3.97%
2022 45,751,000 +4.83%
2023 42,794,000 -6.46%
2024 58,580,000 +36.89%
2025 59,015,000 +0.74%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-01-30 14:21